Muscular strength after CFTR modulators

Long regarded as an incurable disease, cystic fibrosis is now experiencing a historic turning point thanks to the advent of new CFTR modulator therapies and translational research that is redefining clinical perspectives. This conference will bring together three experts - Prof. Emmanuelle Brochiero, Ph.D., Dr. Pierre-Régis Burnel, and Dr. Sophie Gohy - to discuss major advances in the understanding and treatment of cystic fibrosis (mucoviscidosis). Muscular strength evolution after CFTR modulators Dr Sophie Gohy is a pulmonologist and head of the Cystic Fibrosis Reference Center at the Cliniques universitaires Saint-Luc in Brussels, as well as the Smoking Cessation Center. As a clinical researcher with the FNRS, her work focuses on respiratory mucosal immunity and the development of innovative diagnostic tests for cystic fibrosis